Autografting Followed by Nonmyeloablative Immunosuppressive Chemotherapy and Allogeneic Peripheral-Blood Hematopoietic Stem-Cell Transplantation as Treatment of Resistant Hodgkin’s Disease and Non-Hodgkin’s Lymphoma
Angelo Michele Carella(San Antonio College), Maria Teresa Corsetti(Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo), Paola Lambelet(Ospedale Policlinico San Martino), Antonella Romanelli(Ospedale Policlinico San Martino), M. Vinci(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), C Loni(Ospedale Policlinico San Martino), Raimondo Ferrara(Ospedale Policlinico San Martino), M. Valbonesi(Ospedale Policlinico San Martino), Francesco De Stefano(University of Genoa), Graziella Pinotti(Medica (Italy)), Simonetta Verdiani(Ospedale Policlinico San Martino), Enrica Lerma(Ospedale Policlinico San Martino), L. Tedeschi(Ospedale Policlinico San Martino), Marina Cavalierè(McMaster University)
Cited by 228
Related Papers
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer
|New England Journal of Medicine|2014|751
Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial
|The Lancet|2018|733
Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer
|New England Journal of Medicine|2018|684